Ubs Asset Management Americas Inc Dr Reddys Laboratories LTD Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 16,511 shares of RDY stock, worth $220,256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,511
Previous 8,249
100.16%
Holding current value
$220,256
Previous $655,000
60.31%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RDY
# of Institutions
265Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$153 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$150 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$134 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$126 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$74.8 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.21B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...